Hepatitis A immunisation in persons not previously exposed to hepatitis A

Keyphrases

• Immunization 100%
• Hepatitis A 100%
• Hepatitis A Virus 100%
• Virus Vaccine 88%
• Confidence Interval 77%
• Relative Risk 66%
• Inactivated Hepatitis A Vaccine 44%
• Risk of Bias 33%
• Randomized Trial 33%
• Live Attenuated 33%
• Placebo 22%
• Adverse Events 22%
• Low Risk 22%
• Hepatitis A Vaccine 22%
• Live Attenuated Hepatitis A Vaccine 22%
• Protective Efficacy 22%
• Virus Control 22%
• Clinical Analysis 22%
• All Ages 11%
• Protection Level 11%
• MEDLINE 11%
• Cochrane Library 11%
• Embase 11%
• Clinical Efficacy 11%
• Missing Data 11%
• Cochrane 11%
• Cochrane Central Register of Controlled Trials 11%
• Data Risk 11%
• Data Extraction 11%
• Randomized Clinical Trial 11%
• Subgroup Analysis 11%
• Systemic Side Effects 11%
• Risk Assessment 11%
• Risk Ratio 11%
• Science Citation Index Expanded 11%
• Infectious Hepatitis 11%
• Socio-economic Losses 11%
• Hepatitis A Vaccination 11%
• Non-serious 11%
• Systematic Error 11%
• Susceptible Individuals 11%
• Risk of Bias Assessment 11%
• Anti-hepatitis 11%
• Inactivated Vaccine 11%
• Pre-exposure Prophylaxis (PrEP) 11%
• Hepatobiliary 11%
• Seroprotection 11%
• Intention-to-treat Analysis 11%
• China National Knowledge Infrastructure 11%
• Vaccine Types 11%
• Protective Threshold 11%
• Error Bias 11%
• Live Attenuated Vaccine 11%
• Random Error 11%
• Dichotomous Outcomes 11%
• Immunoglobulin G 11%
• Hepatitis A Infection 11%
• Low Quality Data 11%
• Clinical Outcomes 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Hepatitis A Vaccine 72%
• Vaccination Policy 9%
• Inactivated Vaccine 9%
• Immunoglobulin G 9%